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1. Introduction
Sleep is a basic physiological need for all humans. People need to sleep and rest enough for a
healthy and productive life. However, some factors may prevent attainment of adequate sleep
and rest. While some of these factors may cause transient alterations in an individual’s sleep-
rest routine, other factors can affect sleep chronically. Chronic systemic diseases are one of the
most important factors that can affect the characteristics of people’s sleep for a long-time
period. Chronic diseases cause various sleep problems and impair sleep quality. One of the
chronic systemic diseases that affects the sleep routine and sleep quality of people severely is
Chronic Obstructive Pulmonary Disease (COPD).
COPD is an important health problem with an increasing prevalence and high morbidity and
mortality rate all over the world. In the last 20 years, the increasing mortality rates related to
COPD emphasize that COPD is a growing health problem [1]. WHO predicts that COPD will
become the third leading cause of death worldwide by 2030 [2]. The Global Initiative for
Obstructive Lung Disease (GOLD) characterizes COPD as “a preventable and treatable disease
with some significant extra pulmonary effects that may contribute to the severity in individual
patients. The pulmonary component of COPD is characterized by airflow limitation that is not
fully reversible. The airflow limitation is usually progressive and associated with an abnormal
inflammatory response of the lung to noxious particles or gases“. [3]
COPD, which affects individuals multidimensionally, has severe consequences. The com‐
plaints of patients with COPD are not limited to the symptoms of dyspneoa, cough and phlegm
production [4]. Although COPD is a disease affecting primarily the respiratory tract and lungs,
it has many systemic effects and complications related to the cardiovascular system, muscu‐
loskeletal system, neurological system, nutrition, and metabolism [5,6].
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COPD severely affects the social and psychological aspects of patients’ lives as well as their
physical health. Due to the changes of the disease process, COPD forces patients to make
changes in their lifestyles. Due to the stress, anxiety, loss of control and independence, change
of sense of self, and respiratory distress, patients experience important psychological altera‐
tions including serious fear of death and depression [4,7-9]. Patients with COPD have to change
most of their daily activities due to dyspnoea, functional impairment, and fatigue. With
increasing fatigue and dyspnoea, they adopt a sedentary lifestyle [4]. Many patients with
COPD have poor sleep quality, especially those who have high anxiety and depression [10-12].
Shackell et al (2007) stated that the anxiety experienced due to dyspnoea affects the sleep
quality of patients with COPD and the sleep quality has effects on physical and emotional
functions [13]. COPD-related sleep disturbances play a role in its morbidity and adversely
affect quality of life. Poor sleep quality could contribute to poor COPD-related outcomes such
as exacerbations or even mortality risk [14].
2. Oxgen desaturation during sleep in COPD patients and sleep problems
Sleep is a physiological situation that occurs depending on the special functional organization
of the central nervous system. Each individual feels the need to sleep later in the evening and
sleeping occurs generally at night [15]. Normal sleeping is divided into non-rapid eye move‐
ment (NREM) and rapid eye movement (REM). NREM consists of three stages: N1, N2 and
N3 (quiet sleep or delta sleep). Strong stimuli are required to wake up someone whose NREM
stages proceed. REM has tonic and phasic components. REM sleep has a parasympathetically
medicated tonic component and sympathetically mediated phasic component. The phasic
component of REM sleep is characterized by skeletal muscle twitches, increased heart rate
variability, pupil dilation, and increased respiratory rate [16-18]. During NREM sleep, the
metabolic demand of the brain decreases and the blood flow throughout the entire brain
progressively decreases [19-21].
In  order  to  understand  the  effect  of  COPD  on  respiration  during  sleep,  one  should
principally know the physiological changes occurring during the periods of regular sleep
and wakefulness. While the respiratory system provides the oxygen that the body needs
on one part, it helps remove the carbon dioxide produced by the body’s metabolic processes
on the other part. Arrangement of the functions of the respiratory system basically occurs
through negative feedback [3]. Ventilation is normally controlled by a combination of two
systems: a metabolic system responsible for the automatic changes directly related to gas
exchange, and a behavioral system responsible for the voluntary changes originating from
cortical and forebrain structures [22-23].
While metabolic rate decreases during sleep, responses to various chemical, mechanical, and
cortical stimuli also decrease. The respiratory response to the changes observed in the partial
oxygen and partial carbon dioxide pressures in the arterial blood differs significantly in
comparison to the wakefulness period [24]. Especially during REM sleep, such physiological
changes may affect gas exchange and lead to hypoventilation resulting in clinically significant
hypoxemia and hypercapnia in patients with COPD [25].
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The most pronounced hypoxemia occurs during the REM stage of sleep because of the
generalized muscle hypotonia that accompanies this stage [26]. REM-associated hypoxemia
can reach critically low levels, especially in patients with already borderline waking oxygen‐
ation, with potentially deleterious clinical consequences such as cardiac dysrhythmias,
pulmonary hypertension, and polycythemia [21,26].
Sleep affects  respiration through changes  in  control  of  the  respiratory center,  in  airway
resistance, and in muscle contractility. These changes which usually are not consequential
in healthy people may cause problems in patients with COPD. The gas exchange which
occurs during sleep in patients with COPD arises as a result of the nature of the disease
[3,27].  In COPD, breathing against expiratory airflow obstruction becomes more difficult
during sleep when there is reduced tidal volume, ineffective ventilation, and hypoxemia
[28]. Patients with COPD experience the most profound hypoxemia and hypercapnia during
REM sleep  [26].  The  oxygen  desaturation  which  occurs  during  sleep  in  COPD may be
greater than that which occurs during maximal exercise [29]. This desaturation predispos‐
es to cardiac arrhythmias at night [28,30], pulmonary hypertension [28,31,32] and proba‐
bly deaths during acute attacks [33].
FRC=functional residual capacity; FEV1=forced expiratory volume in 1 s; V′/Q′=ventilation/perfusion ratio;(McNicholas
et al. Sleep disorders in COPD: the forgotten dimension. European Respiratory Review. 2013,22(129):365-375.)
Figure 1. Pathophysiology of sleep-related respiratory changes in chronic obstructive pulmonary disease.
COPD patients  develop hypoxia  and hypercapnia  of  varying degrees  depending on the
severity of their lung disease; hyperinflation occurs in the lungs due to air trapping and
work of breathing increases [3]. Oxygen desaturation among the COPD patients is probably
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caused by physiologic hypoventilation that occurs during sleep precipitating a considera‐
ble  decrease  in  the  SaO2  level  of  hypoxemic  patients  [28,34,35].  Hypoventilation  during
sleep is related to impairment of the respiratory center’s response to chemical,  mechani‐
cal and cortical stimuli [26,36, 37].
During sleep, ventilation/perfusion relationships are deranged. Especially in REM sleep, atony
of accessory respiratory muscles develops decreasing functional residual capacity which
further worsens ventilation/perfusion relationships, and hypoxemia intensifies. Decrease of
intercostal muscle activity is important in patients with COPD who rely upon the use of
accessory respiratory muscles to maintain respiration. Lung hyperinflation places the dia‐
phragm, the only functioning respiratory muscle during REM sleep, at a mechanical disad‐
vantage that also impairs oxygenation through alterations in ventilation/perfusion matching
[26,37]. The compensatory efforts of the muscles that assist the diaphragm and hyperinflated
lungs become inefficient after time [18,38] The diaphragm is at a mechanical disadvantage due
to lung hyperinflation which adversely affects the contractile power of diaphragmatic muscle
fibres (type I fibres). Such changes are of paramount importance as they restrict the effective‐
ness of the diaphragm during respiration [39,40]. In order to maintain respiratory effort,
patients utilize accessory muscles in the chest, shoulder and abdomen. Due to atony, accessory
muscles of respiration are unable to augment respiration during REM sleep which results in
flattening of the diaphragm. Because the diaphragm is unable to contribute to ventilation
during REM sleep, minute ventilation declines to half the daytime level. In addition, this
reduction in ventilation is accompanied by deranged ventilation/perfusion (V/Q mismatch)
and adequate gas exchange does not occur. As a result, arterial oxygen decreases and carbon
dioxide increases. These derangements in gas exchange are more prominent among patients
with COPD compared with the general population [21,38].
Drugs such as corticosteroids, methyl xanthenes and β-agonists which are used in the treat‐
ment of COPD also affect the sleep of the patient [41,42]. They can disrupt sleep and provoke
sleeplessness irrespective of the severity of the patient’s respiratory disease [3].
In patients with COPD, nocturnal desaturation and moderate hypoxemia are associated with
an increase in pulmonary artery pressures [31,43,44]. In COPD patients, this hypoxemia
associated rise in pulmonary arterial pressures is reversed with oxygen treatment [37]. In
addition, in patients with COPD, premature ventricular contractions increase during sleep and
oxygen treatment reduces their frequency [30].
The presence of other health problems that accompany COPD affects the occurrence and
severity of sleep disorders. Patients with sleep apnea who do not have COPD experience rapid
normalization of oxygen levels after apnea associated desaturations. However, in patients who
suffer from both COPD and sleep apnea, apnea associated oxygen desaturation is more
profound and longer because these patients are already hypoxic when the apnea begins.
Therefore, patients with COPD are at risk for complications caused by chronic hypoxia like
cor pulmonale and polycythemia [37].
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Krachman et al summarized the potential consequences of changes in ventilatory control and
respiratory muscle function during sleep in patients with chronic obstructive pulmonary
disease (COPD) in Figure 2. [21]
A/W=airways; OSA=obstructive sleep apnea. V/Q=ventilation/perfusion ratio. Vd/Vt=ratio of dead space volume to
tidal volume.
(Krachman et al. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc, 2008, 5(4):536-542)
Figure 2. Potential consequences of changes in ventilatory control and respiratory muscle function during sleep in pa‐
tients with chronic obstructive pulmonary disease (COPD)
3. Evaluation of sleep and sleep quality in COPD patients
Many patients with COPD experience nocturnal respiratory symptoms which interrupt sleep.
When the frequency and severity of night symptoms increase, sleep quality decreases [26].
Sleep quality in patients with COPD is decreased both subjectively and objectively. Indicators
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of poor sleep quality include the subjective complaints of difficulty falling and staying asleep,
morning tiredness, early awakenings, and excessive daytime sleepiness [14,45, 46]. Cormick
et al. asked patients with emphysema about their perception of sleep quality and found that
72% complained of daytime sleepiness, 32% reported impaired daytime concentration, and
28% complained of early morning headaches [14]. Sleeping problems seen in COPD patients
are related to oxygen desaturation which occurs depending on the severity of the disease [37,
47]. During sleep, especially during REM, respiratory muscle function and the responsiveness
of the respiratory centre to chemical stimulants decrease. Thus, COPD patients are at higher
risk of developing nocturnal desaturation. Desaturation during sleep is considered a major
determinant of disturbed sleep among COPD patients [48]. McSerry et al (2012) reported that
sleep quality is poor in patients with severe COPD compared with individuals of similar age
who do not have sleep apnea. Daytime hypoxaemia is independently associated with impaired
sleep efficiency [49]. Kinsman et al. (1983) stated that disordered sleep is the third main
complaint after dyspneoa and fatigue in patients with COPD and approximately half of the
patients experience sleep disruption “always” or “generally always”[50]. Tel at al. (2006)
determined that sleep quality is poor in patients with COPD and there is a significant rela‐
tionship between the anxiety levels of patients and poor sleep quality [11]. Valipour et al. (2011)
determined that compared with healthy people, patients with COPD experience more
insomnia and sleep disorders [51].
Insomnia, nightmares, and somnulence are higher in patients with COPD than in the general
population [52]. Nearly half of the patients with COPD stated that their quality of sleep was
considerably impaired [37]. Valipour et al (2011) determined that insomnia, and sleep-
maintenance difficulty occur frequently in patients with COPD [51]. Polysomnographic
studies show that in patients with COPD, the sleep duration is shortened, arousals and
awakenings occur frequently, and slow wave and REM sleep are shortened [14].
Poor quality of sleep in patients with COPD occurs as a result of many factors: age, severity
of COPD, medications, underlying depression, and underlying sleep disorders [11,13,37,48].
George and Bayliff (2003) showed that the frequency of sleep disorders increases with the
severity of the underlying pulmonary disease in COPD patients [41]. Pulmonary symptoms
experienced by the patients also cause sleep disorders [53]. Omachi et al. (2012) found that
sleep disorders are related to cough, dyspnoea and severity of illness in COPD patients. While
many COPD patients suffer from the problem of excessive secretions, coughing to produce
sputum/secretion results in interruptions in the sleep of the patients. Considering the sleep
habits of the patients, most of them report that their sleep is frequently disrupted due to
respiratory distress, cough and sputum production at night [54]. Using qualitative methods,
Aydın Tel et al. (2012) showed that the majority of patients with COPD stated that their
respiratory symptoms adversely affected their sleep [55].
Examples of patients’ comments illustrating how their COPD affected their sleep include:
Patient A “Due to this disease, everything is problematic, including going to the toilet, having bath,
dressing up, lying on the bed, sitting up and turning right and left. I become short of breath and I can
do nothing.”
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Patient B, “Sometimes I have a stuffed throat and become short of breath during sleep and then wake
up by fluttering. I can never sleep on my back, I always lie laterally. I sleep while sitting and sometimes,
I fall while sleeping.” [55]. Many COPD patients prefer to sleep in a chair instead of lying supine
in order to ease breathing and improve sleeping. This way of sleeping pulls the diaphragm
downwards and relaxes the respiratory mechanism [3]. Thus, COPD patients frequently prefer
this position to sleep more comfortably and soundly.
Sleep disorders are also closely associated with the fatigue experienced by COPD patients.
Patients with sleep disorders suffer from daytime chronic fatigue and lethargy and, therefore,
their life quality is poorer [14, 56]. Poor sleep quality leads to various dysfunctions in COPD
patients by causing daytime excessive sleepiness and changing neuro-cognitive and psycho‐
motor wakefulness [25].
Although the exact impact of chronic sleep disorders on the pulmonary function of COPD
patients is not known, interruptions in sleep may cause slight decreases in the forced vital
capacity as well as at the forced expiratory volume in one second [57].
The most frequent sleep problems detected in patients with COPD are insomnia, waking up
early in the morning, headache, and daytime sleepiness. Their prevalence varies between 30
% and 70 % in COPD patients [14, 45,52]. Klink et al. (1994) reported that 52.8% of COPD
patients suffer from insomnia and daytime lethargy [58]. Subjective complaints related to sleep
problems are accompanied by respiratory symptoms such as cough, dyspnoea, wheezing, and
producing sputum [25]. Sleep disorders associated with COPD affect the quality of sleep
deeply through multiple mechanisms. Omachi et al (2012) showed that sleep disorders
experienced by COPD patients predict utilization of emergency services due to acute COPD
exacerbations [54].
Successful COPD management requires consideration of all of the disease’s effects on each
person, not just from the perspective of COPD’s main respiratory manifestations like dysp‐
neoa, cough, and phlegm. Within this context, the relationship between pulmonary function
and sleep shouldn’t go unnoticed and a careful sleep history should be elicited from all patients
with COPD. The first phase of effective disease management includes a diagnostic assessment
of the patient and collecting the essential data to plan the treatment and care requirements
accurately. Only successful disease management will eliminate the symptoms of COPD and
improve a patient’s clinical course. Hynnien et al. (2007) determined that anxiety, depression,
and sleep disorders are associated with poor health perception by patients. According to their
results, all patients should be assessed for anxiety, depression, sleep disorders, and daily
functions irrespective of the severity/phase of their COPD [59]. Deficiencies in disease
management result in the intensification of COPD symptoms, emergence of sleep disorders,
significant changes in the cognitive functions, deterioration of the disease, and even death.
According to the results of the study conducted by Omachi et al. (2012), the relationship
between sleep and pulmonary disorders in COPD patients is summarized in Figure 3 [54].
Seemingly, sleep disorders are experienced by all COPD patients and may lead to significant
complications although their severities and intensities may be different. Thus, sleep habits of
COPD patients and the factors affecting these habits should be assessed comprehensively [54].
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Figure 3. Omachi et al.(2012) Disturbed sleep among COPD patients is longitudianally associated with mortality and
adverse COPD outcomes. Sleep Med, 2012, 13(5):476-483.
Most patients with COPD have poor sleep quality [11,36, 60,61]. Moreover, some studies
suggest that in COPD patients, sleep quality is the most important health factor affecting
quality of life. [36,62,63]. These results show that all COPD patients should be evaluated for
symptoms of sleep disorders, snoring during sleep and potential sleep apnea syndrome
symptoms like observable apneas [37]. In the clinical evaluation of COPD patients, questions
to determine the sleep quality of patients and the potential existence of sleep apnea syndrome
should be elicited.
Oxygen therapy, drug treatment, non-pharmacological approaches and sleep hygiene are the
interventions recommended for COPD patients suffering from sleep disorders.
When discussing sleep problems in patients with COPD, the patient’s respiratory symptoms
should be discussed. Reduction in respiratory symptoms such as dyspnea and cough may be
the initial management goals that will improve sleep quality [37]. When it is needed, nocturnal
oxygen treatment should be provided and, as far as possible in patients with severe COPD,
the use of hypnotics should be avoided [37]. The most important intervention is to prevent
nocturnal hypoxemia [26]. Nocturnal oxygen treatment is suggested in cases of hypoxemia
complications [37]. In a study of oxygen therapy on sleep quality Calverly et al. (1982)
concluded that oxygen therapy increases REM sleep and sleep continuity and reduces sleep
latency [64].
COPD medications may have varying effects on sleep quality. Theophylline [65] and anticho‐
linergic medicines may ameliorate nocturnal desaturation and ipratropium increases sleep
quality [66]. Ipratropium bromide enhances sleep quality, abrogates nocturnal oxygen
desaturation, improves perceived sleep quality, and increases REM sleep duration without
any effects on other sleep phases or total sleep duration [66]. On the other hand, while some
studies examining the effect of Theophylline on sleep quality reported that it caused deterio‐
ration of sleep quality [65], other studies revealed that it had no effect on sleep quality [67-69].
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Because of the potentional negative effects of benzodiazepines on ventilation, these medicines
should be avoided in patients with COPD [70]. It is recommended not to use benzodiazepines
in the patients with COPD as they may exacerbate the frequency, duration, and severity of
nocturnal hypoxemia [71].
In patients with COPD, treatments that improve lung function and gas exchange should
improve sleep quality and overall health [72]. In COPD patients, good sleep quality also
contributes to better overall health of patients [73]. Soler et al. (2013) showed that pulmonary
rehabilitation is effective in improving the sleep quality of patients with COPD [74]. Increased
awareness by medical professionals of the sleep problems of patients with COPD is important,
since the sleep quality has an effect on patients’ quality of life. In addition to treatment
approaches that improve lung function and help the symptoms of the disease to be brought
under control such as pulmonary rehabilitation, sleep and sleep hygiene education will help
COPD patients acquire a high quality sleep pattern and increase their sleep quality.
Like patients with any chronic disease, patients with COPD who have perceptions of poor
health are likely to experience anxiety, depression, sleep disturbance, and problems with daily
functioning. Lee et al. (2011) suggested that these findings show the need to screen routinely
for sleep disturbance in patients with COPD and support the potential benefits of interventions
to enhance self-efficacy and quality of sleep in reducing depression in COPD patients [75].
There are some studies examining the effectiveness of pulmonary rehabilitation in eliminating
sleep disorders in COPD patients. Soler et al. (2013) showed that pulmonary rehabilitation
produced significant improvements in life quality perceptions of patients in relation to
dyspnoea, exercise tolerance, self-effectiveness and health while 19% of the patients had
improved/advanced sleep quality. Soler et al. (2013) suggested that pulmonary rehabilitation
may be an effective, non-pharmacologic treatment option for sleep problems in patients with
COPD [74].
Most of the patients with COPD suffering from sleep problems report a lack of support from
their physicians and few received advice for sleep problems [13]. Sleep problems in patients
with COPD may need specific evaluation [6]. Assessment of the sleep problems of patients
with COPD is an issue that should not be ignored during routine care. Sleep characteristics of
the patient should be assessed. The impact on sleep duration and quality can be recorded using
validated tools such as the Pittsburgh Sleep Quality Index [76].
Another approach is to measure the emergence of daytime symptoms, such as day time
sleepiness or fatigue, related to sleep deprivation. Daytime sleepiness can be assessed by the
Epworth Sleepiness Scale [77]. The St George’s Respiratory Questionnaire includes one
question about sleep disturbance caused by cough or breathlessness [6]. For assessment of the
impact of night-time symptoms and sleep disturbance in COPD, the COPD and Asthma Sleep
Impact Scale may be used [78]. The patient should be informed adequately about all the
processes in order to engage his/her participation in the practices aimed at solving the sleep
problems. As stress and anxiety due to a lack of information will affect sleep, patients should
be provided with adequate and timely information.
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Restlessness, anxiety, confusion, and sleeplessness experienced by the patients with COPD are
common symptoms of hypoxia and hypoxemia. To detect these symptoms, consciousness level
and mental status of the patient should be monitored routinely. Supporting the positions that
will ease the respiration of the patient and changing the position, if necessary, will help the
patient breathe more comfortably. Patients with COPD frequently prefer sleeping in an upright
position instead of lying on their back [53].
Encouraging and supporting the patients to produce sputum will facilitate clearance of
secretions and ease breathing. To improve sleep quality of patients with COPD, health
professionals can recommend some interventions such as maintaining a regular sleep and
wake schedule, establishing a regular relaxing bedtime routine, restricting their activities in
bed to sleep and sex, not for other stimulating activities, creating a sleep environment that is
cool, dark, and comfortable and avoiding caffeine in the hours before bedtime.
4. Conclusion
Sleep, a physiological necessity, is important for all people in order to attain physical, psy‐
chological, and emotional wellness. However, in some situations, sleep may be stressful for
patients especially those with COPD. Sleep disorders experienced by COPD patients adversely
affect their sleep quality. Although patients with COPD frequently experience sleep problems
and their sleep quality is unsatisfactory, healthcare providers do not review regularly their
sleep characteristics and quality. The routine examination of patients with COPD should
include a review of sleep symptoms and sleep quality to ascertain the effects of sleep distur‐
bances on their lives. Only through the active assessment of a comprehensive sleep history can
sleep disorders be diagnosed and managed. Healthcare personnel who provide holistic care
will assess patients’ sleep problems and symptoms. This approach will help to diagnose sleep
problems early, initiate appropriate interventions and management, and improve patients’
wellness.
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